Literature DB >> 33492571

Association of xenobiotic-metabolizing enzymes (GSTM1 and GSTT 1), and pro-inflammatory cytokines (TNF-α and IL-6) genetic polymorphisms with non-alcoholic fatty liver disease.

Narges Damavandi1,2, Sirous Zeinali3,4,5.   

Abstract

Previous studies have revealed that genetic polymorphisms of the Glutathione S-transferase M1 and T1 (GSTM1 and GSTT1), tumor necrosis factor-α (TNF-α), and interleukin 6 (IL-6) are associated with the presence of non-alcoholic fatty liver disease (NAFLD) in many populations. This study was conducted to investigate the association of the GSTM1, GSTT1, TNF-α rs1800629, and IL-6 rs1800795 with NAFLD in the general Iranian population. A case-control analysis included 242 NAFLD patients and 324 healthy controls from Iranian adults. After the physical examination, the genotypes were determined by polymerase chain reaction(PCR). The GSTM1 null, GSTT1 null, TNF-α AG/AA, and IL-6 CG/CC genotypes were deemed to be high-risk. The null allele of GSTM1 and A allele of TNF-α were more frequent in NAFLD patients even after Bonferroni's correction (P values<0.005, adjusted odds ratio (OR), 1.66 and 2.02; 95% confidence intervals (CI), (1.18-2.32) and (1.34-3.34), respectively. The IL-6 CC/CG genotype association with NAFLD was not significant after correction (P value = 0.04) Polymorphisms of xenobiotic and pro-inflammatory genes are associated with NAFLD in the Iranian population and seem to be a useful tool for NAFLD prevention and care.

Entities:  

Keywords:  GSTM1; GSTT1; IL-6; Non-alcoholic fatty liver; TNF-α

Mesh:

Substances:

Year:  2021        PMID: 33492571     DOI: 10.1007/s11033-021-06142-1

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  34 in total

Review 1.  Nonalcoholic fatty liver disease.

Authors:  Paul Angulo
Journal:  N Engl J Med       Date:  2002-04-18       Impact factor: 91.245

Review 2.  Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease.

Authors:  Giovanni Targher; Christopher P Day; Enzo Bonora
Journal:  N Engl J Med       Date:  2010-09-30       Impact factor: 91.245

3.  A case-control study on the effect of metabolic gene polymorphisms, nutrition, and their interaction on the risk of non-alcoholic fatty liver disease.

Authors:  Luca Miele; Valentina Dall'armi; Consuelo Cefalo; Bojan Nedovic; Dario Arzani; Rosarita Amore; Gianlodovico Rapaccini; Antonio Gasbarrini; Walter Ricciardi; Antonio Grieco; Stefania Boccia
Journal:  Genes Nutr       Date:  2014-01-09       Impact factor: 5.523

Review 4.  Glutathione S-transferase polymorphisms and their biological consequences.

Authors:  J D Hayes; R C Strange
Journal:  Pharmacology       Date:  2000-09       Impact factor: 2.547

5.  Null genotypes of GSTM1 and GSTT1 contribute to hepatocellular carcinoma risk: evidence from an updated meta-analysis.

Authors:  Bin Wang; Gang Huang; Dan Wang; Aijun Li; Zhipeng Xu; Ran Dong; Deqiang Zhang; Weiping Zhou
Journal:  J Hepatol       Date:  2010-06-01       Impact factor: 25.083

Review 6.  Glutathione transferases.

Authors:  John D Hayes; Jack U Flanagan; Ian R Jowsey
Journal:  Annu Rev Pharmacol Toxicol       Date:  2005       Impact factor: 13.820

7.  Association between combinations of glutathione-S-transferase M1, T1 and P1 genotypes and non-alcoholic fatty liver disease.

Authors:  Masaharu Hori; Kentaro Oniki; Takehiro Nakagawa; Keiji Takata; Shuichi Mihara; Toru Marubayashi; Kazuko Nakagawa
Journal:  Liver Int       Date:  2008-05-19       Impact factor: 5.828

Review 8.  Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis.

Authors:  Curtis K Argo; Patrick G Northup; Abdullah M S Al-Osaimi; Stephen H Caldwell
Journal:  J Hepatol       Date:  2009-05-03       Impact factor: 25.083

9.  Interactive effects of smoking and glutathione S-transferase polymorphisms on the development of non-alcoholic fatty liver disease.

Authors:  Kentaro Oniki; Masaharu Hori; Junji Saruwatari; Kazunori Morita; Ayami Kajiwara; Misaki Sakata; Shuichi Mihara; Yasuhiro Ogata; Kazuko Nakagawa
Journal:  Toxicol Lett       Date:  2013-04-30       Impact factor: 4.372

10.  Meta-analysis of genetic polymorphisms in xenobiotic metabolizing enzymes and their association with breast cancer risk.

Authors:  Tajamul Hussain; Salman Alrokayan; Upadhyay Upasna; Manickam Pavithrakumari; Jaganathan Jayapriya; Vijay Kumar Kutala; Shaik Mohammad Naushad
Journal:  J Genet       Date:  2018-06       Impact factor: 1.166

View more
  2 in total

Review 1.  Mitochondrial Mutations and Genetic Factors Determining NAFLD Risk.

Authors:  Siarhei A Dabravolski; Evgeny E Bezsonov; Mirza S Baig; Tatyana V Popkova; Ludmila V Nedosugova; Antonina V Starodubova; Alexander N Orekhov
Journal:  Int J Mol Sci       Date:  2021-04-24       Impact factor: 5.923

2.  Exploring the Protective Effects and Mechanism of Huaji Jianpi Decoction against Nonalcoholic Fatty Liver Disease by Network Pharmacology and Experimental Validation.

Authors:  Hongkun Xue; Yu Wang; Hongwei Xiang; Qi Song; Guowei Zhang; Jianguo Wang; Shaoqin Ge
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-26       Impact factor: 2.650

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.